Diabetes Mellitus Itself Increases Cardio-Cerebrovascular Risk and Renal Complications in Primary Aldosteronism.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 10 01 2020
accepted: 09 04 2020
pubmed: 11 4 2020
medline: 3 2 2021
entrez: 11 4 2020
Statut: ppublish

Résumé

The prevalence of diabetes mellitus (DM) in patients with primary aldosteronism (PA) is higher than in those with essential hypertension and the general population. Although DM is a common major risk factor for cardio-cerebrovascular (CCV) diseases and renal complications, details of its effects in PA have not been demonstrated. The aim of this study was to determine the effects of coexistent DM on the risk of CCV events and progression of renal complications in PA patients. A multi-institutional, cross-sectional study was conducted. PA patients experienced between January 2006 and October 2016 and with available data of CCV events and DM were enrolled from the Japan PA registry of the Japan Primary Aldosteronism Study/Japan Rare Intractable Adrenal Diseases Study (n = 2524). CCV events and renal complications were compared between a DM group and a non-DM group by logistic and liner-regression analysis. DM significantly increased the odds ratio (OR) of CCV events (OR 1.59, 95% CI: 1.05-2.41) and that of proteinuria (OR 2.25, 95% CI: 1.59-3.16). DM correlated significantly with declines in estimated glomerular filtration rate (β = .05, P = .02). This the first report to demonstrate the presence of DM as an independent risk factor for CCV events and renal complications, even in PA patients. Management of DM should be considered in addition to the specific treatment of PA.

Identifiants

pubmed: 32275055
pii: 5818654
doi: 10.1210/clinem/dgaa177
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Aya Saiki (A)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Michio Otsuki (M)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Daisuke Tamada (D)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Tetsuhiro Kitamura (T)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Iichiro Shimomura (I)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Isao Kurihara (I)

Department of Endocrinology, Metabolism, and Nephrology, School of Medicine, Keio University, Tokyo, Japan.

Takamasa Ichijo (T)

Department of Endocrinology and Metabolism, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Japan.

Yoshiyu Takeda (Y)

Department of Internal Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.

Takuyuki Katabami (T)

Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Yokohama City Seibu Hospital, Yokohama, Japan.

Mika Tsuiki (M)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Norio Wada (N)

Department of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo, Japan.

Toshihiko Yanase (T)

Muta Hospital, Fukuoka, Japan.

Yoshihiro Ogawa (Y)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Junji Kawashima (J)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Masakatsu Sone (M)

Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Nobuya Inagaki (N)

Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Takanobu Yoshimoto (T)

Department of Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University, Tokyo, Japan.
Department of Diabetes and Endocrinology, Tokyo Metropolitan Hiroo Hospital Tokyo, Tokyo, Japan.

Ryuji Okamoto (R)

Department of Cardiology, Mie University Hospital, Mie, Japan.

Katsutoshi Takahashi (K)

Division of Metabolism, Showa General Hospital, Tokyo, Japan.

Hiroki Kobayashi (H)

Division of Nephrology, Hypertension, and Endocrinology, Nihon University School of Medicine, Tokyo, Japan.

Kouichi Tamura (K)

Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Kohei Kamemura (K)

Department of Cardiology, Shinko Hospital, Kobe, Japan.

Koichi Yamamoto (K)

Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Shoichiro Izawa (S)

Department of Endocrinology and Metabolism, Tottori University Hospital, Yonago, Japan.

Miki Kakutani (M)

Division of Diabetes, Endocrinology, and Clinical Immunology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Masanobu Yamada (M)

Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Japan.

Akiyo Tanabe (A)

Division of Endocrinology, National Center for Global Health and Medicine, Tokyo, Japan.

Mitsuhide Naruse (M)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Endocrine Center, Ijinkai Takeda General Hospital, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH